We know the genes, but not their functions—to resolve this long-standing bottleneck in microbial research, a joint research ...
The Phase 1/2 trial is a first-in-human, open-label, multi-national study designed to evaluate the safety, tolerability, and efficacy of TSRA-196 in adults with AATD. Trial participants will receive a ...
A research team at The University of Osaka revealed that the loss of heterochromatin can cause a chain reaction leading to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback